ASH 2019 | Practice-changing abstracts in acute myeloid leukemia
The Steering Committee shared the top abstracts from ASH 2019 that they believe could have the greatest impact on clinical practice.
1st NCRI AML academy meeting | Advances in intensive chemotherapy for patients with AML
We spoke to Prof Gert Ossenkoppele at the 1st NCRI AML academy meeting about recent intensive chemotherapy advances for the treatment of patients with AML (acute...
Subscribe to get the best content related to AML delivered to your inbox every month